Sensus Healthcare (SRTS) EBT Margin (2016 - 2025)
Sensus Healthcare's (SRTS) quarterly EBT Margin came in at 60.6% in Q4 2025, down 7557.0% year-on-year from 0.81% in Q4 2024, and down 73.17% quarter-over-quarter from 34.99% in Q3 2025.
Sensus Healthcare (SRTS) EBT Margin (2016 - 2025) Analysis & Trends
Sensus Healthcare's EBT Margin history runs 10 years deep, the most recent figure standing at 60.6% for Q4 2025.
- On a quarterly basis, EBT Margin fell 7557.0% year-over-year to 60.6% in Q4 2025; TTM through Dec 2025 was 35.02%, a 5660.0% decrease from a year earlier, with the FY2025 full-year figure at 35.02%, down 5660.0% from the prior year.
- EBT Margin fell to 60.6% in Q4 2025 per SRTS's latest filing, from 34.99% in the prior quarter.
- Across five years, EBT Margin topped out at 161.64% in Q1 2022 and bottomed at 78.97% in Q1 2023.
- The 5-year median for EBT Margin is 9.25% (2024), against an average of 5.37%.
- Across the five-year window, EBT Margin soared 23531 bps in 2021 and tumbled 24061 bps in 2023, its largest moves.
- Year by year, EBT Margin stood at 40.83% in 2021, then fell by 18 bps to 33.63% in 2022, then jumped by 37 bps to 46.19% in 2023, then slumped by 68 bps to 14.97% in 2024, then slumped by 505 bps to 60.6% in 2025.
- Per Business Quant, the three latest SRTS EBT Margin figures stand at 60.6% (Q4 2025), 34.99% (Q3 2025), and 24.06% (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 12.98% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 14.12% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 18.70% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 22.33% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 27.84% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 22.61% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 4.87% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 9.84% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Sensus Healthcare | 50.14 Mn | 31.81 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -60.60% |
| Sep 30, 2025 | -34.99% |
| Jun 30, 2025 | -24.06% |
| Mar 31, 2025 | -29.51% |
| Dec 31, 2024 | 14.97% |
| Sep 30, 2024 | 20.07% |
| Jun 30, 2024 | 23.71% |
| Mar 31, 2024 | 29.08% |
| Dec 31, 2023 | 46.19% |
| Sep 30, 2023 | -40.43% |
| Jun 30, 2023 | -19.48% |
| Mar 31, 2023 | -78.97% |
| Dec 31, 2022 | 33.63% |
| Sep 30, 2022 | 25.29% |
| Jun 30, 2022 | 38.03% |
| Mar 31, 2022 | 161.64% |
| Dec 31, 2021 | 40.83% |
| Sep 30, 2021 | 3.53% |
| Jun 30, 2021 | -5.15% |
| Mar 31, 2021 | -36.32% |